| 09.09.2025 07:00 | APTA | Notification of dealings by a director/PDMR | RNS |
| 02.09.2025 20:08 | AVG, SFR, TGP | TRADING UPDATES: Avingtrans US nuclear win; Severfield trading in line | Alliance |
| 02.09.2025 07:00 | APTA | Therapeutic development agreement with Invizius | RNS |
| 28.08.2025 07:00 | APTA | Block Listing Interim Review | RNS |
| 27.08.2025 15:19 | APTA | Aptamer shares rise as launches new biomarker discovery service | Alliance |
| 27.08.2025 10:24 | VCP, BANK, APTA | AIM WINNERS & LOSERS: Aptamer launches new biomarker service | Alliance |
| 27.08.2025 07:00 | APTA | Biomarker Discovery Service Launch | RNS |
| 22.08.2025 13:30 | APTA | Aptamer shares jump amid progress in enzyme inhibitor licensing deals | Alliance |
| 22.08.2025 07:00 | APTA | Update on licensing and development progress | RNS |
| 19.08.2025 07:00 | APTA | Exercise of warrants | RNS |
| 18.08.2025 22:11 | GLR, CIZ, KAV | EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract | Alliance |
| 18.08.2025 15:44 | APTA | Holding(s) in Company | RNS |
| 18.08.2025 07:00 | APTA | Contract extension with global pharma partner | RNS |
| 08.08.2025 07:00 | APTA | Investor Technical Webinar | Reach |
| 07.08.2025 17:24 | APTA | Holding(s) in Company | RNS |
| 05.08.2025 08:05 | APTA | Holding(s) in Company | RNS |
| 01.08.2025 22:05 | HSW, MET, CDGP | EARNINGS AND TRADING: Inspecs revenue dented by tariff uncertainty | Alliance |
| 31.07.2025 13:29 | APTA | Investor Webinar | Reach |
| 31.07.2025 07:00 | APTA | Trading Update | RNS |
| 28.07.2025 12:25 | APTA | Holding(s) in Company | RNS |
| 24.07.2025 11:48 | APTA | Result of General Meeting | RNS |
| 21.07.2025 19:59 | TYM, EME, VRCI | TRADING UPDATES: Aptamer gets more Unilever work; Creo "confident" | Alliance |
| 21.07.2025 07:00 | APTA | Additional work commissioned by Unilever | RNS |
| 18.07.2025 07:00 | APTA | Issue of Equity in lieu of Non-Exec Director Fees | RNS |
| 17.07.2025 14:22 | PNN, XTR, TAM | UK shareholder meetings calendar - next 7 days | Alliance |
| 09.07.2025 14:53 | APTA | Holding(s) in Company | RNS |
| 08.07.2025 07:00 | APTA | Posting of Circular and Notice of General Meeting | RNS |
| 04.07.2025 11:36 | APTA | IN BRIEF: Aptamer raises GBP2 million for Optimer commercialisation | Alliance |
| 04.07.2025 07:00 | APTA | Placing to raise £2.0 million | RNS |
| 30.06.2025 07:00 | APTA | Liver fibrosis breakthrough with Optimer® platform | RNS |
| 25.06.2025 07:00 | APTA | Agreement with global life sciences leader | RNS |
| 30.05.2025 10:40 | ULVR, MATD, HVO | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | Alliance |
| 30.05.2025 09:44 | ULVR, APTA | Aptamer cheers second product development deal with Unilever | Alliance |
| 30.05.2025 07:00 | APTA | Unilever second Optimer development programme | RNS |
| 15.05.2025 10:36 | PEBB, APTA, DSW | AIM WINNERS & LOSERS: Aptamer wins deals; DSW beats market view | Alliance |
| 15.05.2025 07:01 | APTA | Aptamer Announces New Data at ASGCT | RNS |
| 15.05.2025 07:00 | APTA | Optimer licensing agreements and repeat contracts | RNS |
| 06.05.2025 07:00 | APTA | Alzheimer’s test advanced and royalty agreement | RNS |
| 30.04.2025 07:00 | APTA | Licensing agreed for Optimer as vaccine adjuvant | RNS |
| 29.04.2025 07:00 | APTA | Aptamer Presenting at ASGCT Annual Meeting | Reach |
| 24.04.2025 07:00 | APTA | New Corporate Presentation and Investor Factsheet | Reach |
| 11.03.2025 07:00 | APTA | Interim Results | RNS |
| 04.03.2025 15:12 | SYNT, SUPR, TCAP | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.02.2025 12:50 | APTA | TR-1: Standard form notification of major holdings | RNS |
| 25.02.2025 07:01 | APTA | Block Listing Interim Review | RNS |
| 25.02.2025 07:00 | APTA | Notice of Results and Investor Presentation | RNS |
| 28.01.2025 14:56 | APTA | Issue of Equity in lieu of Director fees | RNS |
| 28.01.2025 07:00 | APTA | Half Year Trading Update | RNS |
| 13.01.2025 11:40 | APTA | Notification of dealings by a director/PDMR | RNS |
| 03.01.2025 12:02 | APTA | Aptamer signs development contract with biopharmaceutical firm | Alliance |
| 30.12.2024 07:00 | APTA | Holding(s) in Company | RNS |
| 19.12.2024 16:44 | APTA | Notification of dealings by a director/PDMR | RNS |
| 19.12.2024 07:00 | APTA | New Development Contract | RNS |
| 18.12.2024 10:53 | APTA | TR-1: Standard form notification of major holdings | RNS |
| 16.12.2024 11:28 | APTA | Notification of dealings by a director/PDMR | RNS |
| 10.12.2024 12:54 | APTA, VCP, HTWS | DIRECTOR DEALINGS: Helios Towers director buys GBP200,000 in shares | Alliance |
| 06.12.2024 07:00 | APTA | New Scientific Advisory Board Members | RNS |
| 05.12.2024 19:52 | SURE, CLC, EMVC | EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations | Alliance |
| 05.12.2024 07:00 | APTA | Technical Update | RNS |
| 04.12.2024 07:00 | APTA | Investor Webinar | Reach |
| 29.11.2024 11:05 | APTA | Results of 2024 Annual General Meeting | RNS |
| 29.11.2024 07:00 | APTA | AGM Statement | RNS |
| 22.11.2024 11:35 | SLP, MSMN, EUZ | UK shareholder meetings calendar - next 7 days | Alliance |
| 07.11.2024 10:46 | FADL, APTA, DSW | AIM WINNERS & LOSERS: Fadel lowers forecasts on contract setbacks | Alliance |
| 07.11.2024 07:00 | APTA | Agreement extended with genetic medicines customer | RNS |
| 06.11.2024 07:00 | APTA | Commercial Trading Update | RNS |
| 05.11.2024 07:00 | APTA | Posting of Annual Report and Notice of AGM | RNS |
| 22.10.2024 07:00 | APTA | Full Year Results for the 12mths to 30 June 2024 | RNS |
| 17.10.2024 07:00 | APTA | Notice of Results and Investor Presentation | RNS |
| 16.09.2024 07:00 | APTA | Director Appointment | RNS |
| 03.09.2024 11:05 | ULVR, APTA | Aptamer Group extends Optimer development contract with Unilever | Alliance |
| 03.09.2024 07:00 | APTA | Aptamer extends contract with Unilever | RNS |
| 27.08.2024 07:00 | APTA | Block listing Interim Review | RNS |
| 20.08.2024 14:26 | APTA | Holding(s) in Company | RNS |
| 16.08.2024 13:04 | APTA | TR-1: Standard form notification of major holdings | RNS |
